Health
Foresight Diagnostics demonstrates the benefits of PhasED-Seq technology at the ICML meeting – News-Medical.Net – Fior Reports
Foresight Diagnostics, the emerging leader in the monitoring of blood-based lymphoma diseases, announced today that the clinical…
Foresight Diagnostics, the emerging leader in the monitoring of blood-based lymphoma diseases, announced today that the clinical performance of its Minimal Residual Disease Detection Platform (MRD) in Diffuse B-Cell Large Cell Lymphoma (DLBCL) will be presented…
Continue Reading
-
Noosa News24 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News13 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News23 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
General20 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76